Cite
Rao TR, Usha PR, Naidu MU, et al. Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures. Curr Ther Res Clin Exp. 2003;64(9):685-96doi: 10.1016/j.curtheres.2003.09.014.
Rao, T. R., Usha, P. R., Naidu, M. U., Gogtay, J. A., & Meena, M. (2003). Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures. Current therapeutic research, clinical and experimental, 64(9), 685-96. https://doi.org/10.1016/j.curtheres.2003.09.014
Rao, Takallapalli Ramesh Kumar, et al. "Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures." Current therapeutic research, clinical and experimental vol. 64,9 (2003): 685-96. doi: https://doi.org/10.1016/j.curtheres.2003.09.014
Rao TR, Usha PR, Naidu MU, Gogtay JA, Meena M. Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures. Curr Ther Res Clin Exp. 2003 Nov;64(9):685-96. doi: 10.1016/j.curtheres.2003.09.014. PMID: 24944416; PMCID: PMC4053054.
Copy
Download .nbib